Skip to main content
Erschienen in: Endocrine 2/2024

15.01.2024 | Original Paper

Thyroid gland: a rare site of metastasis

verfasst von: Ana María Orlandi, Graciela Alcaraz, Laila Bielski, Gabriela Brenta, Lorena Castro Jozami, Andrea Cavallo, Jorgelina Guerra, Santiago Zund, on behalf of the Thyroid Department of Sociedad Argentina de Endocrinología y Metabolismo

Erschienen in: Endocrine | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Despite its rich vascularity, metastasis (MTS) to the thyroid tissue is unusual, ranging from 1 to 3%. This entity is not usually considered as differential diagnosis and is not included in the upfront approach in patients with thyroid nodules. Once diagnosed, treatment is controversial. The aim of this study was to evaluate diagnosis, treatment, and outcome at the end of follow-up in patients with a diagnosis of MTS to the thyroid.

Methods

A retrospective multicenter study was designed from 1985 to 2022; 29 patients with MTS to the thyroid gland were included in the analysis.

Results

Clinical presentation included the presence of a nodular goiter (65.5%), compression symptoms (17.2%), diffuse goiter (10.3%), and suspicious lymph nodes in the neck (7%). Primary tumor sites were: kidney (44.8%), breast (24.1%), lung (13.8%), neuroendocrine system (6.9%), colon (3.4%), cervix (3.4%), and ovary (3.4%). In 18/23 patients, suspicious ultrasound criteria for malignancy were described. Preoperative diagnosis was made in 23/27 patients by FNA and confirmed in 18 cases by immunohistochemistry. Seventeen patients underwent surgery. At the end of the follow-up, 19 patients had died of oncological disease, and six were alive (2/6 disease-free with isolated intrathyroidal MTS).

Conclusion

Renal carcinoma was the tumor that most frequently metastasized to the thyroid gland. Immunodiagnosis was a very useful tool for etiological confirmation. Patients with MTS to the thyroid gland as a unique site had a more favorable course compared to patients with multiple metastatic sites. Finally, outcomes and prognosis essentially depended on the biology of the primary tumor.
Literatur
1.
Zurück zum Zitat Virchow R. Pathologie des Tumeurs. Aronssohn s French translation Germer -Baulliere, Libraire Editeur Vol 2, pag 283 and vol 3 pag 2431871 Virchow R. Pathologie des Tumeurs. Aronssohn s French translation Germer -Baulliere, Libraire Editeur Vol 2, pag 283 and vol 3 pag 2431871
12.
13.
Zurück zum Zitat H. Gharib, E. Papini, J.R. Garber, D.S. Duick, R.M. Harrell, L. Hegedüs, R. Paschke, R. Valcavi, P. Vitti; AACE/ACE/AME Task Force on Thyroid Nodules, American Association Of Clinical Endocrinologists, American College Of Endocrinology, And Associazione Medici Endocrinologi Medical Guidelines For Clinical Practice For The Diagnosis And Management Of Thyroid Nodules-2016 Update. Endocr. Pract. 22(5), 622–639 (2016). https://doi.org/10.4158/EP161208.GLCrossRefPubMed H. Gharib, E. Papini, J.R. Garber, D.S. Duick, R.M. Harrell, L. Hegedüs, R. Paschke, R. Valcavi, P. Vitti; AACE/ACE/AME Task Force on Thyroid Nodules, American Association Of Clinical Endocrinologists, American College Of Endocrinology, And Associazione Medici Endocrinologi Medical Guidelines For Clinical Practice For The Diagnosis And Management Of Thyroid Nodules-2016 Update. Endocr. Pract. 22(5), 622–639 (2016). https://​doi.​org/​10.​4158/​EP161208.​GLCrossRefPubMed
15.
Zurück zum Zitat M.K. Nakhjavani, H. Gharib, J.R. Goellner, J.A. van Heerden, Metastasis to the thyroid gland. A report of 43 cases. Cancer 79(3), 574–578 (1997). doi:10.1002/(sici) 1097-0142(19970201)79:3<574: aid-cncr21>3.0.co;2-#CrossRefPubMed M.K. Nakhjavani, H. Gharib, J.R. Goellner, J.A. van Heerden, Metastasis to the thyroid gland. A report of 43 cases. Cancer 79(3), 574–578 (1997). doi:10.1002/(sici) 1097-0142(19970201)79:3<574: aid-cncr21>3.0.co;2-#CrossRefPubMed
16.
Zurück zum Zitat M. Pusztaszeri, H. Wang, E.S. Cibas, C.N. Powers, M. Bongiovanni, S. Ali, K.K. Khurana, P.J. Michaels, W.C. Faquin, Fine-needle aspiration biopsy of secondary neoplasms of the thyroid gland: a multi-institutional study of 62 cases. Cancer Cytopathol. 123(1), 19–29 (2015). https://doi.org/10.1002/cncy.21494CrossRefPubMed M. Pusztaszeri, H. Wang, E.S. Cibas, C.N. Powers, M. Bongiovanni, S. Ali, K.K. Khurana, P.J. Michaels, W.C. Faquin, Fine-needle aspiration biopsy of secondary neoplasms of the thyroid gland: a multi-institutional study of 62 cases. Cancer Cytopathol. 123(1), 19–29 (2015). https://​doi.​org/​10.​1002/​cncy.​21494CrossRefPubMed
20.
24.
Zurück zum Zitat T. Berge, S. Lundberg, Cancer in Malmö 1958–1969. an autopsy study. Acta Pathol. Microbiol. Scand. Suppl. (260), 1–235 (1977). T. Berge, S. Lundberg, Cancer in Malmö 1958–1969. an autopsy study. Acta Pathol. Microbiol. Scand. Suppl. (260), 1–235 (1977).
27.
Zurück zum Zitat J.D. Mortensen, L.B. Woolner, W.A. Bennett, Secondary malignant tumors of the thyroid gland. Cancer. 9(2), 306–309 (1956). 10.1002/1097-0142(195603/04)9:2<306: aid-cncr2820090217>3.0.co;2-iCrossRefPubMed J.D. Mortensen, L.B. Woolner, W.A. Bennett, Secondary malignant tumors of the thyroid gland. Cancer. 9(2), 306–309 (1956). 10.1002/1097-0142(195603/04)9:2<306: aid-cncr2820090217>3.0.co;2-iCrossRefPubMed
35.
Zurück zum Zitat J. Rosai, M.L. Carcangiu, R.A. DeLellis, J. Rosai, L.H. Sobin, Tumors of the thyroid gland. Atlas of Tumor Pathology. (Armed Forces Institute of Pathology. American Registry of Pathology, Washington DC, 1992), pp. 65–121. J. Rosai, M.L. Carcangiu, R.A. DeLellis, J. Rosai, L.H. Sobin, Tumors of the thyroid gland. Atlas of Tumor Pathology. (Armed Forces Institute of Pathology. American Registry of Pathology, Washington DC, 1992), pp. 65–121.
40.
Zurück zum Zitat U. Beutner, C. Leowardi, U. Bork, C. Lüthi, I. Tarantino, S. Pahernik, M.N. Wente, M.W. Büchler, B.M. Schmied, S.A. Müller, Survival after renal cell carcinoma metastasis to the thyroid: single center experience and systematic review of the literature. Thyroid 25(3), 314–324 (2015). https://doi.org/10.1089/thy.2014.0498CrossRefPubMed U. Beutner, C. Leowardi, U. Bork, C. Lüthi, I. Tarantino, S. Pahernik, M.N. Wente, M.W. Büchler, B.M. Schmied, S.A. Müller, Survival after renal cell carcinoma metastasis to the thyroid: single center experience and systematic review of the literature. Thyroid 25(3), 314–324 (2015). https://​doi.​org/​10.​1089/​thy.​2014.​0498CrossRefPubMed
41.
Zurück zum Zitat F. Calzolari, P.V. Sartori, C. Talarico, D. Parmeggiani, E. Beretta, L. Pezzullo, G. Bovo, P. Sperlongano, M. Monacelli, R. Lucchini, C. Misso, A. Gurrado, M. D’Ajello, F. Uggeri, E. Puxeddu, P. Nasi, M. Testini, L. Rosato, A. Barbarisio, N. Avenia, Surgical treatment of intrathyroid metastases: preliminary results of a multicentric study. Anticancer Res. 28(5B), 2885–2888 (2008)PubMed F. Calzolari, P.V. Sartori, C. Talarico, D. Parmeggiani, E. Beretta, L. Pezzullo, G. Bovo, P. Sperlongano, M. Monacelli, R. Lucchini, C. Misso, A. Gurrado, M. D’Ajello, F. Uggeri, E. Puxeddu, P. Nasi, M. Testini, L. Rosato, A. Barbarisio, N. Avenia, Surgical treatment of intrathyroid metastases: preliminary results of a multicentric study. Anticancer Res. 28(5B), 2885–2888 (2008)PubMed
42.
Zurück zum Zitat J. Cao, Y.E. Yu, N.N. Li, Y.X. Wu, J.N. Shi, M.Y. Fang, Thyroid metastasis from non-small cell lung cancer. Int. J. Clin. Exp. Pathol. 12(8), 3013–3021 (2019)PubMedPubMedCentral J. Cao, Y.E. Yu, N.N. Li, Y.X. Wu, J.N. Shi, M.Y. Fang, Thyroid metastasis from non-small cell lung cancer. Int. J. Clin. Exp. Pathol. 12(8), 3013–3021 (2019)PubMedPubMedCentral
45.
Zurück zum Zitat I. Iesalnieks, H. Winter, E. Bareck, G.C. Sotiropoulos, P.E. Goretzki, M. Klinkhammer-Schalke, S. Bröckner, A. Trupka, M. Anthuber, H. Rupprecht, M. Raab, W. Meyer, F. Reichmann, M. Kästel, M. Mayr, W. Braun, H.J. Schlitt, A. Agha, Thyroid metastases of renal cell carcinoma: clinical course in 45 patients undergoing surgery. Assessment of factors affecting patients’ survival. Thyroid 18(6), 615–624 (2008). https://doi.org/10.1089/thy.2007.0343CrossRefPubMed I. Iesalnieks, H. Winter, E. Bareck, G.C. Sotiropoulos, P.E. Goretzki, M. Klinkhammer-Schalke, S. Bröckner, A. Trupka, M. Anthuber, H. Rupprecht, M. Raab, W. Meyer, F. Reichmann, M. Kästel, M. Mayr, W. Braun, H.J. Schlitt, A. Agha, Thyroid metastases of renal cell carcinoma: clinical course in 45 patients undergoing surgery. Assessment of factors affecting patients’ survival. Thyroid 18(6), 615–624 (2008). https://​doi.​org/​10.​1089/​thy.​2007.​0343CrossRefPubMed
Metadaten
Titel
Thyroid gland: a rare site of metastasis
verfasst von
Ana María Orlandi
Graciela Alcaraz
Laila Bielski
Gabriela Brenta
Lorena Castro Jozami
Andrea Cavallo
Jorgelina Guerra
Santiago Zund
on behalf of the Thyroid Department of Sociedad Argentina de Endocrinología y Metabolismo
Publikationsdatum
15.01.2024
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2024
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-023-03626-x

Weitere Artikel der Ausgabe 2/2024

Endocrine 2/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.